Irbesartan And Hydrochlorothiazide
Product Images NDC 54868-6457

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 54868-6457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (30s 150 12.5 Btl)

Label for Irbesartan and Hydrochlorothiazide Tablets USP 150 mg / 12.5 mg, showing a quantity of 30 film-coated tablets. The label includes manufacturer information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., details on storage conditions, and dosage instructions referencing prescribing information. The label also includes barcodes and space for batch number and expiration date.*

FDA Label Image

6457.jpg (6457)

Label for Irbesartan and Hydrochlorothiazide tablets 150 mg/12.5 mg, distributed by Physicians Total Care, Inc., Tulsa, OK. The label indicates a 30 tablet package with lot number 000 and expiration date 01/60. Manufactured by Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Figure1a.jpg (Figure1a)

A line graph showing the percentage of subjects with systolic blood pressure below 140 mmHg plotted against baseline systolic blood pressure. Five lines represent data from different studies labeled as Irbesartan (Irb.) and Hydrochlorothiazide (HCTZ) studies V and VI, illustrating comparative blood pressure control outcomes.*

FDA Label Image

Figure1b.jpg (Figure1b)

A line graph depicting the percentage of systolic blood pressure (SBP) below 130 mmHg against baseline SBP values ranging from 140 to 220 mmHg. The graph compares results from various studies involving Irbesartan (Irb), Hydrochlorothiazide (HCTZ), and their combination, using different line styles to represent each study group.*

FDA Label Image

Figure2a.jpg (Figure2a)

A line graph showing percentage change in diastolic blood pressure (DBP) below 90 mmHg versus baseline DBP in mmHg. The graph compares five groups from two studies: Irbesartan and Hydrochlorothiazide (Irb. HCTZ) Study V, Irbesartan (Irb.) Study V, HCTZ Study V, Irbesartan and Hydrochlorothiazide Study VI, and Irbesartan Study VI, each depicted with different line styles.*

FDA Label Image

Figure2b.jpg (Figure2b)

A line graph showing the relationship between baseline diastolic blood pressure (DBP) in mmHg on the x-axis and the percentage of subjects with DBP less than 80 mmHg on the y-axis. The graph includes multiple study lines comparing Irbesartan alone, Hydrochlorothiazide alone, and their combination across Study V and Study VI.*

FDA Label Image

Figure3 (Figure3)

A graph showing the relationship between Irbesartan dose (mg/day) on the x-axis and placebo-subtracted systolic blood pressure (SBP) reduction in mmHg on the y-axis. The figure illustrates an integrated exposure-response plot with data points and a fitted curve demonstrating increased SBP reduction with higher Irbesartan doses.*

FDA Label Image

Figure4 (Figure4)

A scatter plot with a curve showing placebo-subtracted reduction in trough systolic blood pressure (mmHg) versus irbesartan dose (mg). The x-axis represents irbesartan dose up to 900 mg, and the y-axis shows systolic blood pressure reduction ranging from -2 to 8 mmHg.*

FDA Label Image

Hydrochlorothiazide (Hydrochlorothiazide)

Chemical structure of the active ingredients in Irbesartan and Hydrochlorothiazide, depicting the molecular arrangement with sulfonamide, chlorine, and other functional groups visible in the diagram.*

FDA Label Image

Irbesartan (Irbesartan)

Chemical structure diagram of the active ingredient Irbesartan. The diagram shows the molecular arrangement including rings and functional groups characteristic of Irbesartan.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.